The total number of scientific publications in immunology in China has shown robust growth from 2013 to 2023, particularly notable from 2020 onwards. The year-on-year variation peaked at 44.91% in 2021, with a steady decline to 23.22% in 2023. The CAGR over the last five years stands at an impressive 26.72%, indicating a strong upward momentum in research output.
Future trends to watch for include:
- A forecasted steady growth with a 5-year CAGR of 10.04%, showing sustained interest and investment in immunology research.
- Increased focus on novel immunotherapies and personalized medicine driven by China’s expanding healthcare sector.
- Possible fluctuations in publication volume influenced by global health events and governmental research funding policies.
